Data from the United States about the THC pills marketplace shows new consumers are entering the cannabis market, which is useful news for investors in marijuana
Speculation among investors about the potential size of the recreational cannabis market in Canada runs the gamut from wild-eyed to dour, with plenty of room in between.
Dour probably misses the mark. Wild-eyed is highly discouraged. But the continuum of commercial possibility for investors in Canada next year looks potentially solid, based on trends in the United States.
Read more “Cannabis Categories Suggest Marketplace Expansion”
As Canada moves closer to introducing legal recreational cannabis, investors in marijuana begin to see the outlines of regulations within the provinces
With just months to go until recreational marijuana sales are scheduled to be legal across Canada (on Nov. 29 the House of Commons passed Bill C-45, which legalizes cannabis; now the Senate must pass the bill before it becomes law in July) regulators are beginning to shape how commercial cannabis will look in their provinces. While cannabis will be legal in every province, the rules surrounding cannabis will vary from province to province. As we march towards legalization, we all should play close attention to how regulations are firming up in the provinces. For investors in marijuana, the shape and scope of the provincial regulations will be paramount.
Read more “Marijuana Investors’ Guide to Canada Cannabis Regulations”
Vancouver, BC, November 27, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1), through its interests in two Access to Cannabis for Medical Purposes Regulations (“ACMPR“) license holders, its wholly-owned subsidiary Acreage Pharms Ltd. (“Acreage Pharms”) and its one-third interest in AB Laboratories Inc. (“AB Labs”), continues to execute plans that will achieve production capacity of 6,000 kg commencing January 2018, several months before Canada expects cannabis to become recreationally legal. Total current annual production capacity at both locations is approximately 1,500 kg.
As announced on October 27, 2017, Health Canada had removed previously disclosed production capacity restrictions at both Acreage Pharms and AB Labs.
Read more “Invictus MD Provides Update on ACMPR Sales License Amendment as it Prepares for Legalization”
News coverage about marijuana investing in Canada sometimes suggests the industry is nearing a plateau, and that it already is mature.
Don’t believe it.
Entrepreneurs and investors have been participating in the cannabis industry for a few years in Canada and the United States, but it remains a fledgling industry. We all remain on the ground floor, which can be a good place for investors. Especially if you are investing in marijuana in Canada.
As Canada marches towards full recreational legalization in 2018, the country stands apart for investors. By this time next year, Canada should be the only Western country in the world with recreational legalization in place in all directions, although provinces will likely enact regulations that differ from one another.
Read more “Three Things to Keep in Mind for Investors in Canadian Marijuana”